-
Start Preamble
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application; correction.
SUMMARY:
The Drug Enforcement Administration (DEA) published a document in the Federal Register on August 12, 2021, concerning a notice of application. The document indicated the approved drug code (1205—Lisdexamfetamine) as a schedule I. The correct drug schedule should read schedule II.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of August 12, 2021, in FR Doc. 2021-17181 (86 FR 44405), on page 44406, in the first column, in the controlled substance table, correct the drug schedule to schedule II.
Start SignatureEnd Signature End Supplemental InformationBrian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2022-00852 Filed 1-21-22; 8:45 am]
BILLING CODE P
Document Information
- Published:
- 01/24/2022
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application; correction.
- Document Number:
- 2022-00852
- Pages:
- 3587-3587 (1 pages)
- Docket Numbers:
- Docket No. DEA-875
- PDF File:
- 2022-00852.pdf